Family history fails to identify many children with severe hypercholesterolemia

T J Starc1, P F Belamarich, S Shea

  • 1Department of Pediatrics, Columbia University, College of Physicians and Surgeons, New York, NY.

Insights

Family history screening is insufficient for identifying children with hypercholesterolemia. Many children with high cholesterol, even severe cases, are missed by this approach, indicating a need for broader screening strategies.

Area of Science:

  • Pediatrics
  • Cardiovascular Health
  • Genetics

Background:

  • Identifying children with hypercholesterolemia is crucial for preventing future cardiovascular disease.
  • Current guidelines suggest limiting cholesterol testing to children with specific family histories.

Purpose of the Study:

  • To evaluate the effectiveness of comprehensive family histories in identifying children with hypercholesterolemia.

Main Methods:

  • Studied 114 children referred for hypercholesterolemia treatment.
  • Assessed family histories for hyperlipidemia and premature coronary heart disease based on American Academy of Pediatrics guidelines.
  • Analyzed cholesterol levels against age-based percentiles.

Main Results:

  • A significant percentage of children with elevated cholesterol (22% above 75th percentile, 18.3% above 95th percentile) had negative family histories.
  • Among children with hypercholesterolemia and positive family histories, hyperlipidemia was more common (72 families) than premature heart disease (27 families).

Conclusions:

  • Family history alone is inadequate for identifying children with hypercholesterolemia, including those with severe elevations.
  • Hyperlipidemia history is more prevalent than premature heart disease history in families of affected children.

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...